LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension
Public ClinicalTrials.gov record NCT01373086. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Proof-of-concept Study to Evaluate the Efficacy and Safety of LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the efficacy and safety of LFF269 compared to placebo after treatment in subjects with essential hypertension.
Study identification
- NCT ID
- NCT01373086
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 19 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2011 (Type not available)
- Primary completion
- Oct 2011 (Actual)
- Completion
- Oct 2011 (Actual)
- Last update posted
- Dec 17, 2020
2011
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Clinical Research Institute-Phase I | Anaheim | California | 92801 | — |
| Comprehensive Phase I | Fort Myers | Florida | 333901 | — |
| Comprehensive Phase One®, | Miramar | Florida | 33025 | — |
| Comprehensive NeuroScience | St. Petersburg | Florida | 33716 | — |
| Clinical Research Atlanta | Stockbridge | Georgia | 30281 | — |
| Clinical Research Advantage/ Prairie Fields Family Medicine, PC | Fremont | Nebraska | 68025 | — |
| Internal Medicine Physicians | Omaha | Nebraska | 68130 | — |
| ICON Developmental Solutions | Omaha | Nebraska | 68154 | — |
| Clinical Research Advantage/ Aloha Medical | Las Vegas | Nevada | 89183 | — |
| ICON Development Solutions, | San Antonio | Texas | 78209 | — |
| Comprehensive Clinical Development NW, Inc. | Tacoma | Washington | 98418 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01373086, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2020 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01373086 live on ClinicalTrials.gov.